These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36311725)

  • 1. Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease.
    Krüger T; Wehner R; Herbig M; Kräter M; Kramer M; Middeke JM; Stölzel F; List C; Egger-Heidrich K; Teipel R; Oelschlägel U; Wermke M; Jambor H; Wobus M; Schetelig J; Jöhrens K; Tonn T; Subburayalu J; Schmitz M; Bornhauser M; von Bonin M
    Front Immunol; 2022; 13():1005554. PubMed ID: 36311725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis.
    Servais S; Baron F; Lechanteur C; Seidel L; Baudoux E; Briquet A; Selleslag D; Maertens J; Poire X; Schroyens W; Graux C; De Becker A; Zachee P; Ory A; Herman J; Kerre T; Beguin Y
    Front Immunol; 2023; 14():1106464. PubMed ID: 36817464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
    Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
    Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of multipotent mesenchymal stromal cells used for acute graft-versus-host disease prophylaxis.
    Kuzmina LA; Petinati NA; Shipounova IN; Sats NV; Bigildeev AE; Zezina EA; Popova MD; Drize NJ; Parovichnikova EN; Savchenko VG
    Eur J Haematol; 2016 Apr; 96(4):425-34. PubMed ID: 26115424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.
    Fujii S; Miura Y; Fujishiro A; Shindo T; Shimazu Y; Hirai H; Tahara H; Takaori-Kondo A; Ichinohe T; Maekawa T
    Stem Cells; 2018 Mar; 36(3):434-445. PubMed ID: 29239062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliable isolation of human mesenchymal stromal cells from bone marrow biopsy specimens in patients after allogeneic hematopoietic cell transplantation.
    Krüger T; Middeke JM; Stölzel F; Mütherig A; List C; Brandt K; Heidrich K; Teipel R; Ordemann R; Schuler U; Oelschlägel U; Wermke M; Kräter M; Herbig M; Wehner R; Schmitz M; Bornhäuser M; von Bonin M
    Cytotherapy; 2020 Jan; 22(1):21-26. PubMed ID: 31883948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients.
    Bonig H; Kuçi Z; Kuçi S; Bakhtiar S; Basu O; Bug G; Dennis M; Greil J; Barta A; Kállay KM; Lang P; Lucchini G; Pol R; Schulz A; Sykora KW; Teichert von Luettichau I; Herter-Sprie G; Ashab Uddin M; Jenkin P; Alsultan A; Buechner J; Stein J; Kelemen A; Jarisch A; Soerensen J; Salzmann-Manrique E; Hutter M; Schäfer R; Seifried E; Paneesha S; Novitzky-Basso I; Gefen A; Nevo N; Beutel G; Schlegel PG; Klingebiel T; Bader P
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease.
    Ringdén O; Gustafsson B; Sadeghi B
    Front Immunol; 2020; 11():567210. PubMed ID: 33193339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial.
    Zhao K; Lin R; Fan Z; Chen X; Wang Y; Huang F; Xu N; Zhang X; Zhang X; Xuan L; Wang S; Lin D; Deng L; Nie D; Weng J; Li Y; Zhang X; Li Y; Xiang AP; Liu Q
    J Hematol Oncol; 2022 Mar; 15(1):22. PubMed ID: 35255929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear factor erythroid 2-related factor 2 agonist tert-butylhydroquinone improves bone marrow mesenchymal stromal cell function in prolonged isolated thrombocytopenia after allogeneic haematopoietic stem cell transplantation.
    Luo XY; Kong Y; Lv M; Mo XD; Wang Y; Xu LP; Zhang XH; Huang XJ; Tang FF
    Br J Haematol; 2023 Mar; 200(6):759-768. PubMed ID: 36464324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease.
    Stenger E; Giver CR; Langston A; Kota D; Das PK; Chinnadurai R; Galipeau J; Waller EK; Qayed M
    Front Immunol; 2022; 13():959658. PubMed ID: 36189324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity.
    Ding L; Ning HM; Li PL; Yan HM; Han DM; Zheng XL; Liu J; Zhu L; Xue M; Mao N; Guo ZK; Zhu H; Wang HX
    Stem Cell Res Ther; 2020 Mar; 11(1):119. PubMed ID: 32183881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
    Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
    J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Protein Secretion by Multipotent Mesenchymal Stromal Cells Effective and Ineffective in the Prevention of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
    Petinati NA; Drize NI; Arapidi GP; Shender VO; Lagar'kova MA; Kuz'mina LA; Parovichnikova EN; Savchenko VG
    Bull Exp Biol Med; 2022 May; 173(1):128-132. PubMed ID: 35618969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease.
    Zhao L; Chen S; Yang P; Cao H; Li L
    Stem Cell Res Ther; 2019 Jun; 10(1):182. PubMed ID: 31227011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
    Johnstone BH; Messner F; Brandacher G; Woods EJ
    Front Immunol; 2021; 12():622604. PubMed ID: 33732244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment].
    Kuzmina LA; Petinati NA; Vasilieva VA; Dovydenko MV; Drokov MY; Davydova YO; Kapranov NM; Sats NV; Chabaeva YA; Kulikov SM; Gaponova TV; Drize NI; Parovichnikova EN; Savchenko VG
    Ter Arkh; 2020 Sep; 92(7):23-30. PubMed ID: 33346442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.